| scholarly article | Q13442814 |
| P2093 | author name string | Neri G | |
| Nichols BL | |||
| Di Ferrante N | |||
| Donnelly PV | |||
| Hrgovcic R | |||
| Berglund RK | |||
| P2860 | cites work | The defect in Hurler and Hunter syndromes. II. Deficiency of specific factors involved in mucopolysaccharide degradation | Q33818834 |
| The glycosaminoglycans of human plasma | Q35567892 | ||
| Hurler's syndrome. A genetic study in cell culture | Q36267955 | ||
| Hurler's syndrome. Effect of retinol (vitamin A alcohol) on cellular mucopolysaccharides in cultured human skin fibroblasts | Q36268654 | ||
| OCCURRENCE OF URINARY ACID MUCOPOLYSACCHARIDES IN THE HURLER SYNDROME. | Q37617165 | ||
| TISSUE STORAGE OF MUCOPOLYSACCHARIDES IN HURLER-PFAUNDLER'S DISEASE. | Q37689876 | ||
| Enzyme Replacement in Fabry's Disease, an Inborn Error of Metabolism | Q43631124 | ||
| Scheie and Hurler syndromes: apparent identity of the biochemical defect | Q44041974 | ||
| Hurler's syndrome: demonstration of an inherited disorder of connective tissue in cell culture | Q44085362 | ||
| Fibroblasts in culture during mucopolysaccharidoses: the effect of serum on metachromasy | Q45002704 | ||
| Hyaluronidase and sulfatase deficiency in Hurler's syndrome | Q48916083 | ||
| Biochemical and ultrastructural studies in Hurler's syndrome | Q49124990 | ||
| Characterization of the factor deficient in the Hunter syndrome by polyacrylamide gel electrophoresis | Q53691190 | ||
| Failure to induce scurvy by ascorbic acid depletion in a patient with Hurler's syndrome. | Q53697004 | ||
| The effect of retinol (vitamin-A alcohol) on urinary excretion of mucopolysaccharides in the Hurler syndrome. | Q53760383 | ||
| Enzymatic studies of urinary chondroitin sulfates in normal and systemic connective tissue disease states. | Q53842483 | ||
| Gargoylism; a mucopolysaccharidosis. | Q54575823 | ||
| Therapeutic trials in the inborn errors. An attempt to modify Hurler's syndrome. | Q54588959 | ||
| The genetic mucopolysaccharidoses | Q68375779 | ||
| Mucopolysaccharidosis type 3. Morphologic and biochemical studies of two siblings with Sanfilippo syndrome | Q68386099 | ||
| The measurement of urinary mucopolysaccharides | Q68403167 | ||
| Hurler and Hunter syndromes: mutual correction of the defect in cultured fibroblasts | Q68428517 | ||
| Vitamin A and mucopolysaccharidosis: a clinical and biochemical evaluation | Q68446949 | ||
| Inborn errors of mucopolysaccharide metabolism | Q68456821 | ||
| Periodate oxidation of acid polysaccharides inhibition by the electrostatic field of the substrate | Q68586369 | ||
| Lysosomal hyaluronidase from rat liver. II. Properties | Q72332799 | ||
| Turbidimetric measurement of acid mucopolysaccharides and hyaluronidase activity | Q74025335 | ||
| THE PRESENCE OF HYALURONIDASE IN VARIOUS MAMMALIAN TISSUES | Q76693898 | ||
| A method for the separation of acid mucopolysaccharides: its application to the isolation of heparin from the skin of rats | Q79020331 | ||
| Determination of 2-deoxy-2-sulfoaminohexose content of mucopolysaccharides | Q79438292 | ||
| A modified uronic acid carbazole reaction | Q79594151 | ||
| Increased urinary excretion of chondroitin sulfate A and C in Hunter's syndrome | Q93800237 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 5 | |
| P304 | page(s) | 303-307 | |
| P577 | publication date | 1971-02-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Induced degradation of glycosaminoglycans in Hurler's and Hunter's syndromes by plasma infusion | |
| P478 | volume | 68 |
| Q39753157 | A Case of Disseminated Hemangiomatosis with Cutaneous, Hepatic and Skeletal Manifestations and Increased Urinary Excretion of Glycosaminoglycans |
| Q70442208 | A clinical trial of fibroblast transplantation for the treatment of mucopolysaccharidoses |
| Q68489826 | A distinct biochemical deficit in the Maroteaux-Lamy syndrome (mucopolysaccharidosis VI) |
| Q40084938 | Advances in the Treatment of Inherited Metabolic Diseases |
| Q39888630 | Adventures in viscous solutions |
| Q45345302 | Allelism, non-allelism, and genetic compounds among the mucopolysaccharidoses |
| Q42868531 | An inverse relationship between heparin content and antibody response in genetically selected mice. Sex effect and evidence of a polygenic control for skin heparin concentration |
| Q68055863 | Attempted enzyme replacement using human amnion membrane implantations in mucopolysaccharidoses |
| Q49557884 | Cell therapy for diverse central nervous system disorders: inherited metabolic diseases and autism |
| Q35224054 | Chemical and Biochemical Aspects of the Glycosaminoglycans and Proteoglycans in Health and Disease |
| Q39765725 | Clinical and biochemical expression of a unique mucopolysaccharidosis |
| Q42093363 | Colorimetric measurement of dermatan sulphate |
| Q41573371 | Correction of feline arylsulphatase B deficiency (mucopolysaccharidosis VI) by bone marrow transplantation |
| Q38081868 | Current and emerging management options for patients with Morquio A syndrome |
| Q37482680 | Effect of leukocyte transfusion in a child with type II mucopolysaccharidosis |
| Q37051044 | Emerging trends in transplantation of inherited metabolic diseases |
| Q59080562 | Enzyme replacement therapy by fibroblast transplantation in a case of Hunter syndrome |
| Q37035071 | Enzyme replacement therapy by fibroblast transplantation: long-term biochemical study in three cases of Hunter's syndrome |
| Q34628680 | Enzyme replacement therapy for the mucopolysaccharide storage disorders |
| Q39931176 | Genetic Disorders Associated with Mental Retardation: Clinical Aspects |
| Q39759187 | Genetic prognosis in severe mental handicap |
| Q39787642 | Heart Volume and Myocardial Connective Tissue during Development and Regression of Thyroxine-Induced Cardiac Hypertrophy in Rats |
| Q35079584 | Hematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelines |
| Q39956684 | Hereditary Diseases?Causes, Cures, and Problems |
| Q54141031 | Hunter's syndrome and Cooley's anaemia in the same patient. Effect of multiple transfusions. |
| Q40769698 | Hurler-like disorders in infancy |
| Q68487172 | Impaired sulphated glycosaminoglycan metabolism in a patient with GM-2 gangliosidosis (Tay-Sachs disease) |
| Q35926081 | Inborn errors of metabolism: principles and their applications |
| Q39744075 | Increased breakdown of glycosaminoglycans and appearance of corrective enzyme after skin transplants in Hunter syndrome |
| Q24626527 | Intravenous administration of phosphorylated acid alpha-glucosidase leads to uptake of enzyme in heart and skeletal muscle of mice |
| Q72805084 | Isolation and structural studies of heparan sulfates and chondroitin sulfates from three species of molluscs |
| Q34425239 | Long-term effects of bone marrow transplantation in dogs with mucopolysaccharidosis I. |
| Q48605013 | Long‐term effects of bone marrow transplantation on lysosomal enzyme replacement in β‐glucuronidase‐deficient mice |
| Q40774431 | Lysosomal storage diseases: mechanisms of enzyme replacement therapy |
| Q36728931 | Metabolic correction and cross-correction of mucopolysaccharidosis type II (Hunter syndrome) by retroviral-mediated gene transfer and expression of human iduronate-2-sulfatase |
| Q62427907 | Monitoring of sulfated polysaccharide content in marine sponges by Raman spectroscopy |
| Q34302974 | Mucopolysaccharidoses and mucolipidoses |
| Q89762313 | Mucopolysaccharidosis Type II: One Hundred Years of Research, Diagnosis, and Treatment |
| Q35200047 | N-acetylgalactosamine-6-sulfate sulfatase in man. Absence of the enzyme in Morquio disease |
| Q69227654 | Ocular changes in the mucopolysaccharidoses after bone marrow transplantation. A preliminary report |
| Q53678934 | Plasma infusions in an infant with Hurler's syndrome. |
| Q40367761 | Quantitative aspects of pinocytosis and the intracellular fate of N-acetyl-alpha-D-glucosaminidase in Sanfilippo B fibroblasts |
| Q48200022 | Recombinant caprine 3H-[N-acetylglucosamine-6-sulfatase] and human 3H-[N-acetylgalactosamine-4-sulfatase]: plasma clearance, tissue distribution, and cellular uptake in the rat. |
| Q33678920 | Replacement therapy in the mucopolysaccharidoses |
| Q39849638 | Sanfilippo A syndrome in the fetus |
| Q68512672 | Serum dependency of cellular phenotype in mucopolysaccharidoses: the influence of autologous serum on metachromasia |
| Q40350253 | Serum α-N-acetylglucosaminidase: Determination, Characterization, and Corrective Activity in Sanfilippo B Fibroblasts |
| Q39730462 | The Effect of Dextran Infusions on Glycosaminoglycan Excretion in the Sanfilippo Syndrome |
| Q36271914 | The Hurler syndrome: a study of cultured lymphoid cell lines |
| Q72840337 | The Urinary Excretion of Heparan Sulfate by Juvenile- and Adult-Onset Diabetic Patients |
| Q34719775 | The defect in the Hurler and Scheie syndromes: deficiency of -L-iduronidase |
| Q41523080 | The future for gene therapy--a reevaluation |
| Q33586932 | The mucopolysaccharidoses |
| Q28610244 | The mucopolysaccharidoses: inborn errors of glycosaminoglycan catabolism |
| Q93728965 | Treatment of Hurler syndrome |
| Q36501354 | Trends in haematopoietic cell transplantation for inborn errors of metabolism |
| Q39745289 | Urinary Excretion of Glycosaminoglycans in Malignant Diseases of the Haemopoietic and Lymphatic Tissues |
| Q41284144 | Urinary excretion of glycosaminoglycans in normal and stone forming subjects |
| Q73565876 | Urine glycosaminoglycan concentrations in mucopolysaccharidosis VI-affected cats following bone marrow transplantation or leukocyte infusion |
Search more.